07 Trade & Services Boosts LUMIRADX, Adds Vanguard & iShares ETFs

TL;DR

**07 Trade & Services just made a huge bet on LUMIRADX LTD, buying over 5.3 million shares!**

AI Summary

CVS Health Corp's 13F-HR filing for the period ending December 31, 2023, reveals that 07 Trade & Services, an investment manager, significantly increased its holdings in LUMIRADX LTD, now owning 5,352,106 shares. This filing also shows new positions in Vanguard Whitehall Fds (252,032 shares) and iShares Core High Dividend ETF (273,110 shares). This matters to investors because it indicates a notable institutional bet on LUMIRADX LTD and a strategic move into dividend-focused ETFs, potentially signaling confidence in these assets or a shift in investment strategy by 07 Trade & Services.

Why It Matters

This filing provides transparency into the investment decisions of 07 Trade & Services, offering insights into which stocks and ETFs they are buying or selling, which can influence other investors' perceptions and actions.

Risk Assessment

Risk Level: medium — The significant concentration in LUMIRADX LTD by 07 Trade & Services introduces a medium risk due to the potential volatility of a single stock, especially one with a smaller market cap.

Analyst Insight

A smart investor would research LUMIRADX LTD to understand the rationale behind 07 Trade & Services' significant investment and evaluate if it aligns with their own risk tolerance and investment goals, while also noting the diversification into ETFs.

Key Numbers

• 5,352,106 — Shares of LUMIRADX LTD (Represents a significant sole holding by 07 Trade & Services, indicating a strong conviction in this company.)
• 252,032 — Shares of VANGUARD WHITEHALL FDS (A new sole holding by 07 Trade & Services, diversifying their portfolio.)
• 273,110 — Shares of ISHARES CORE HIGH DIVIDEND ETF (A new sole holding by 07 Trade & Services, suggesting a move towards income-generating assets.)
• 20231231 — Conformed Period of Report (The date for which the reported holdings are accurate, providing a snapshot of the portfolio at year-end.)
• 20240209 — Filed As Of Date (The date the filing was submitted, indicating the recency of the disclosed information.)

Key Players & Entities

• CVS HEALTH Corp (company) — the company whose 13F-HR filing is being analyzed
• 07 Trade & Services (company) — the filer/investment manager
• LUMIRADX LTD (company) — a company in which 07 Trade & Services holds 5,352,106 shares
• VANGUARD WHITEHALL FDS (company) — a fund in which 07 Trade & Services holds 252,032 shares
• ISHARES CORE HIGH DIVIDEND ETF (company) — an ETF in which 07 Trade & Services holds 273,110 shares
• Michael Motolo (person) — Investment Manager for 07 Trade & Services
• $136,837,471 (dollar_amount) — value of SPDR S P 500 ETF TRUST holdings

Forward-Looking Statements

• 07 Trade & Services will continue to hold or increase its position in LUMIRADX LTD in the next quarter. (LUMIRADX LTD) — medium confidence, target: 2024-03-31
• The new positions in VANGUARD WHITEHALL FDS and ISHARES CORE HIGH DIVIDEND ETF indicate a strategic shift towards more diversified or income-generating assets for 07 Trade & Services. (07 Trade & Services) — high confidence, target: 2024-06-30

FAQ

Filing Documents

• primary_doc.html (13F-HR)
• primary_doc.xml (13F-HR) — 2KB
• infotable.html (INFORMATION TABLE)
• infotable.xml (INFORMATION TABLE) — 3KB
• 0000947871-24-000102.txt ( ) — 7KB

From the Filing

SEC FORM 13F-HR The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 12-31-2023 Check here if Amendment    Amendment Number: This Amendment (Check only one.):    is a restatement.    adds new holdings entries. Institutional Investment Manager Filing this Report: Name: CVS HEALTH Corp Address: ONE CVS DR. WOONSOCKET , RI   02895 Form 13F File Number: 028-22498 CRD Number (if applicable): 001-01011 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Michael Motolo Title: Investment Manager Phone: Signature, Place, and Date of Signing: /s/ Michael Motolo Woonsocket ,  RI 02-09-2024 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)    13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)    13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 6 Form 13F Information Table Value Total: 193,740,036 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] NONE

View Full Filing

View this 13F-HR filing on SEC EDGAR